Kathy A. Gately - Publications

A workflow for assessing antibody-drug conjugate target expression on circulating tumour cells from triple-negative breast cancer and epithelial ovarian cancer patients.

Journal: The journal of liquid biopsy

Published: April 09, 2026

RETRACTED: Richards et al. Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). Int. J. Mol. Sci. 2023, 24, 10545.

Journal: International journal of molecular sciences

Published: March 23, 2026

Size-exclusion chromatography as a clinically applicable method for extracellular vesicles collection as liquid biopsies shows potential diagnostic relevance and correlation with poorer outcome in common cancer types.

Journal: Translational oncology

Published: February 26, 2026

Liquid biopsies for detection, characterization, and interception of therapy resistance in thoracic malignancies.

Journal: Frontiers in oncology

Published: February 08, 2026

Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination.

Journal: British journal of cancer

Published: April 16, 2025

A pilot study evaluating the feasibility of enriching and detecting circulating tumour cells from peripheral and ovarian veins in rare epithelial ovarian carcinomas.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: December 23, 2024

Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma.

Journal: Cancer letters

Published: July 04, 2024

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer.

Journal: Molecular oncology

Published: February 05, 2024

RETRACTED: Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC).

Journal: International journal of molecular sciences

Published: May 03, 2023

Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: February 14, 2023

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC.

Journal: Cancers

Published: February 08, 2021

Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.

Journal: Scientific reports

Published: November 12, 2020